Company
Sola Biosciences, Inc.
Our JUMP70 platform activates the body’s natural protein-folding machinery to selectively fix or remove misfolded proteins treating diseases at their molecular roots.
Also known as Sola Biosciences
- Business model
- B2B
- Headquarters
- Boston, United States
- Founded
- 2016
- Legal name
- SOLA Biosciences
Claim, correct or request removal
Record updated 28 September 2026
About
Research and development of therapeutics for neurodegenerative diseases caused by aggregated proteins
Funding snapshot
- Latest round
- Undisclosed2025-01-25
Funding rounds
- Series Pre-A+ The Second Financing
- 2025-01-25
- Series Pre-A+
- 2024-09-01
Products
- JUMP70 platform
- SOL-175
- Other
- SOL-257
- JUMP70 platform
- SOL-257
- JUMP70 platform
- SOL-368
- JUMP70 platform
- SOL-410
Loading relationship preview